Pulmatrix Inc. said its shareholders approved a proposal to implement a reverse split of the company's common shares.
The proposal sought the implementation of the split before the company's 2019 annual shareholders' meeting at a ratio in the range of 1-for-4 to 1-for-10.
The Lexington, Mass.-based biopharmaceutical company added that there was no immediate plan to implement the reverse stock split.
